SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Pierre Borczuk who wrote (290)6/16/1999 10:11:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
Nothing on the big movers (507 for psoriasis or AlloMune), but there's this.......

"A trial evaluating MEDI-507 for treatment of GvHD in
steroid-resistant BMT patients has been completed and results are expected to be presented at the International Society for
Hematology in Monaco in July."

It's in the thread.



To: Pierre Borczuk who wrote (290)6/16/1999 2:28:00 PM
From: Pierre Borczuk  Read Replies (1) | Respond to of 1475
 
There may be a buyer in BTRN ...again noting 5200x2 = 10k block at ask

at 14:22 14:24 on T&S

Pierre


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News